SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-May-23 9:21 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-23 | Payment of Exercise | 5,577 | $0.87 | $4,851.99 | (1%) 530.41K to 524.84K | |
26-Jan-23 5:15 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-23 | Payment of Exercise | 9,608 | $1.26 | $12,106.10 | (2%) 540.02K to 530.41K | 9% |
09-Aug-22 5:23 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 08-Aug-22 | Purchase | 150,000 | $1.55 | $232,500.00 | 38% 390.02K to 540.02K | |
20-May-22 4:25 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-22 | Payment of Exercise | 6,273 | $1.40 | $8,782.20 | (2%) 396.29K to 390.02K | |
26-Jan-22 4:30 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-22 | Payment of Exercise | 9,607 | $1.13 | $10,855.90 | (2%) 405.9K to 396.29K | (2%) |
20-Dec-21 5:03 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 16-Dec-21 | Market Purchase | 93,800 | $1.07 | $100,366.00 | 30% 312.1K to 405.9K | (8%) |
20-May-21 4:07 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-21 | Payment of Exercise | 6,621 | $3.12 | $20,657.50 | (2%) 318.72K to 312.1K | 2% |
26-Jan-21 7:03 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-21 | Payment of Exercise | 9,687 | $4.46 | $43,204.00 | (3%) 328.41K to 318.72K | (3%) |
20-May-20 9:47 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-20 | Grant | 73,253 | -- | -- | 29% 255.16K to 328.41K | |
30-Jan-20 5:39 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 28-Jan-20 | Payment of Exercise | 9,197 | $7.00 | $64,379.00 | (3%) 264.35K to 255.16K | |
28-Jan-19 5:49 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-19 | Grant | 104,849 | -- | -- | 66% 159.5K to 264.35K |